HZO
MarineMax, Inc.
HZO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NIO
NIO Inc.
NIO has a slight edge over HZO overall, supported by stronger fundamentals and lower modeled downside.
HZO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Weak |
HZO's cash flow is currently healthy, and its profitability is stable, but its revenue and balance sheet are under pressure.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
HZO PE Valuation
HZO has no meaningful PE right now: it lost money over the past year.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
HZO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect HZO's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over HZO on the outlook, with more favorable revenue expectations.
HZO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | — |
| Q3 2026 | -$0.41 | +$1.02 |
HZO lost $0.41 per share over the past year, a smaller loss than the year before.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over HZO in the latest year-over-year earnings comparison.
HZO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $520.1M | -5.8% |
| Q2 2026 | $611.3M | -7% |
| Q1 2026 | $527.4M | -16% |
| Q4 2025 | $505.2M | +7.8% |
HZO's revenue has slid since its 2025 peak: $520M last quarter, down 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 6.1% | +12 points |
| Q1 2026 | 2% | -1.6 points |
| Q4 2025 | 1% | -7.4 points |
| Q3 2025 | 2.5% | N/A |
| Q2 2025 | -6.3% | N/A |
| Q1 2025 | 3.6% | N/A |
| Q4 2024 | 8.3% | N/A |
HZO has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over HZO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
HZO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $77.2M | +13% |
| Q1 2026 | $44.5M | -26% |
| Q4 2025 | $8.3M | +$172.7M |
HZO and NIO do not have enough comparable growth data to identify a winner.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
HZO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.1% | +1.1M shares |
| 1 year | +7.6% | +1.6M shares |
HZO has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q2 2025 | $15M |
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
HZO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.8x | High |
| Q1 2026 | 22.5x | High |
| Q4 2025 | 18.3x | High |
| Q3 2025 | 11.3x | High |
| Q2 2025 | 10.4x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 5.3x | High |
HZO's net debt is about 6.8 years of its operating earnings (EBITDA), down from 10 years a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HZO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.2 | Overbought |
| Stochastic | 96.4 | Overbought |
HZO's weekly RSI is 78 (overbought) and its Stochastic is 96 (overbought).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
HZO PE vs Consumer Cyclical Sector
| Metric | HZO | Sector median | Relative |
|---|---|---|---|
| PE | 203x | 18x | 1,026% above |
| PE % | 100 | 47 | 53 pts above |
HZO has no meaningful PE right now: it lost money over the past year.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
HZO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.6 | 0.5% above |
| 20 week MA | $47.2 | 12% above |
| 50 week MA | $36.4 | 45% above |
| 100 week MA | $30.6 | 72% above |
| 200 week MA | $31.1 | 70% above |
HZO has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
HZO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $37.8 | +127% |
| 2021 | $37.8 | $56.3 | +49% |
| 2022 | $56.3 | $31.0 | -45% |
| 2023 | $31.0 | $38.9 | +26% |
| 2024 | $38.9 | $27.8 | -29% |
| 2025 | $27.8 | $24.5 | -12% |
| 2026 YTD | $24.5 | $52.8 | +116% |
HZO has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.